YZi Labs announced an investment in the biotech company Renewal Bio
BlockBeats News, November 11th. According to official sources, YZi Labs announced an investment in Renewal Bio, a regenerative medicine company that utilizes developmental biology technology to generate DNA-matched human cells and tissues from patient-derived pluripotent stem cells.
Renewal Bio addresses global organ and cell shortages through its Stembroid development platform, which can generate human cells and tissues that are fully genetically matched to the donor DNA for transplantation.
This new round of funding will accelerate the preclinical development of Stembroid-derived hematopoietic stem cells (HSCs) for leukemia and immune disorders and expand research on liver, heart, and pancreatic cells.
You may also like
Stablecoins are the "royalists" of the crypto world: Open USD brings the old currency system into play
Semiconductor stocks plummet, yet Anthropic wants to create a 2nm chip
Where is Zhao Changpeng's billion-dollar investment going? YZi Labs' investment landscape fully revealed
Ethereum Foundation Report: A Basic Guide to Ethereum for Governments and Financial Institutions
A pre-announced harvesting case: After the cryptocurrency price dropped by 99%, the public chain Saga exited to transform into AI
When American giants collectively "defect" from Chinese AI models
BIS Report Compliance Observation: The Real Risks of Stablecoins, Not Just "Depegging"
Portugal 2-1 Croatia: Ronaldo's 20-Year Knockout-Stage Drought Ends With a Debt Finally Collected
Portugal beat Croatia 2-1 in the 2026 global football championship's knockout rounds as Ronaldo scored his first-ever knockout-stage goal, Gonçalo Ramos struck a stoppage-time winner, and VAR ruled out a late equalizer for offside.
